Nucleocapsid Protein Boosts Humoral and Cellular Immune Responses Specific to Spike and RBD in Protein-Based SARS-CoV-2 Vaccination - Poll - DentalSpire

Nucleocapsid Protein Boosts Humoral and Cellular Immune Responses Specific to Spike and RBD in Protein-Based SARS-CoV-2 Vaccination

  • By

  • Stina Gröhn

  • Heini Lehto

  • Saana Soppela

  • Rauno A. Naves

  • Mikael A. Ritvos

  • Alina Iakubovskaia

  • Vili Lampinen

  • Iiris Mustonen

  • Sanniina Pakkala

  • Elizaveta Husu

  • Laura Kakkola

  • Ilkka Julkunen

  • Pekka Kolehmainen

  • Arja Pasternack

  • Olli Ritvos

  • Minna M. Hankaniemi

  • January 29, 2026

  • 0 min

Share

Original Source(s)

Nucleocapsid Protein Boosts Humoral and Cellular Immune Responses Specific to Spike and RBD in Protein-Based SARS-CoV-2 Vaccination

  • by Stina Gröhn, Heini Lehto, Saana Soppela, Rauno A. Naves, Mikael A. Ritvos, Alina Iakubovskaia, Vili Lampinen, Iiris Mustonen, Sanniina Pakkala, Elizaveta Husu, Laura Kakkola, Ilkka Julkunen, Pekka Kolehmainen, Arja Pasternack, Olli Ritvos, Minna M. Hankaniemi

  • January 29, 2026

Related Content

From Epidemics to Pandemics: Over a Decade of Strengthening SARInet Laboratory Surveillance and Response for Respiratory Viruses in the Americas

The impact of the SARS-CoV-2 pandemic on umbilical cord blood transplantation in Japan: insights from an interrupted time series analysis

Infant CD4 T-Cell Response to SARS-CoV-2 mRNA Vaccination Is Restricted in Cytokine Production and Modified by Vaccine Manufacturer